- Home
- EBTC vs DNA Comparison
EBTC vs DNA Comparison
Compare EBTC & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBTC
- DNA
- Stock Information
- Founded
- EBTC 1989
- DNA 2008
- Country
- EBTC United States
- DNA United States
- Employees
- EBTC 570
- DNA N/A
- Industry
- EBTC Major Banks
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EBTC Finance
- DNA Health Care
- Exchange
- EBTC Nasdaq
- DNA Nasdaq
- Market Cap
- EBTC 455.5M
- DNA 423.5M
- IPO Year
- EBTC 2005
- DNA N/A
- Fundamental
- Price
- EBTC $36.65
- DNA $6.37
- Analyst Decision
- EBTC
- DNA Hold
- Analyst Count
- EBTC 0
- DNA 6
- Target Price
- EBTC N/A
- DNA $37.80
- AVG Volume (30 Days)
- EBTC 17.5K
- DNA 1.2M
- Earning Date
- EBTC 10-22-2024
- DNA 11-12-2024
- Dividend Yield
- EBTC 2.62%
- DNA N/A
- EPS Growth
- EBTC N/A
- DNA N/A
- EPS
- EBTC 2.91
- DNA N/A
- Revenue
- EBTC $164,115,000.00
- DNA $217,951,000.00
- Revenue This Year
- EBTC N/A
- DNA N/A
- Revenue Next Year
- EBTC N/A
- DNA $12.85
- P/E Ratio
- EBTC $12.60
- DNA N/A
- Revenue Growth
- EBTC N/A
- DNA N/A
- 52 Week Low
- EBTC $22.60
- DNA $5.26
- 52 Week High
- EBTC $39.37
- DNA $75.20
- Technical
- Relative Strength Index (RSI)
- EBTC 63.78
- DNA 33.79
- Support Level
- EBTC $36.51
- DNA $8.13
- Resistance Level
- EBTC $38.47
- DNA $10.07
- Average True Range (ATR)
- EBTC 1.32
- DNA 0.70
- MACD
- EBTC 0.29
- DNA -0.14
- Stochastic Oscillator
- EBTC 66.50
- DNA 8.87
About EBTC Enterprise Bancorp Inc
Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.